Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study

Background: Agomelatine is a melatonin agonist and 5HT antagonist developed for the treatment of major depressive disorder which also has some effects on the circadian system. Since circadian dysfunctions are thought to play a role in the pathophysiology of depression, some of the mechanism of actio...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Psychiatry
Main Authors: Robillard, Rebecca, Carpenter, Joanne S., Feilds, Kristy-Lee, Hermens, Daniel F., White, Django, Naismith, Sharon L., Bartlett, Delwyn, Whitwell, Bradley, Southan, James, Scott, Elizabeth M., Hickie, Ian B.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Psychiatry
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6297866/
https://ncbi.nlm.nih.gov/pubmed/30618853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2018.00624
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki